Skip to main content

Five-minute Q & A: Data & analytics for planning

Computer with graphs and analytics displayed. Notepad and phone sit next to computer.

New trends and change agents are increasingly challenging health systems’ volume and revenue growth. To compete and stay relevant, they must take a more balanced approach to their near-, mid-and long-term growth.

DataGen and Sg2 recently joined forces to host Optimizing strategic planning for revenue growth: DataGen and Sg2 resources. This webinar featured customers' experiences using Sg2's suite of analytical tools and how, when partnered with DataGen's customized customer service and training, these tools helped their organization optimize its strategic planning for enhanced revenue growth. 

We broke down five common questions asked during the session.

1.       What disruptors are you keeping an eye on? 

  • We are keeping an eye on four major disruptors: Retail clinics, big tech/digital, VC-backed medical groups and payers as providers. 

2.       What downstream effects have these disruptors had on inpatient volumes? 

  • Nationally, IP utilization has remained well below pre-pandemic levels through Q2 2022. Through Sg2’s partnership with Strata Decision Technology, we compared adult quarterly volumes from 2019 vs. 2020-2022. Across the country, there is a decline of 10% when you include COVID-19 diagnosis and 14% when you exclude COVID-19 diagnosis. 

3.       What downstream effects have these disruptors had on outpatient volumes? 

  • Outpatient volume demonstrates recovery and growth beyond pre-pandemic levels. According to Strata Decision Technology, the adult quarterly volumes, including COVID-19 from 2019 vs. 2020-2022, revealed OP, OP surgery and E&M are all up between 4% and 5%, while ED visits are flat.  

4.       What are some key 2022 forecast considerations? 

  • Endemic COVID-19 
  • Rising patient acuity  
  • Shift to OP slowing 
  • Expanded care at home capabilities 
  • Record MA enrollment 

5.       What does today’s winning growth portfolio look like? 

  • Near-term: Drive an optimal patient mix through the existing footprint. 
  • Mid-term: Increase revenue and margin capture for patients you serve. 
  • Long-term: Evolve and expand the footprint to win more patients. 
Struggling to get a comprehensive view of your market, competitive position and growth opportunities to guide your strategic planning? Check out how DataGen's partnership with Sg2 can help.
Labels:

Comments

Post a Comment

Popular posts from this blog

CMS Enhancing Oncology Model Updates: RFA Issued for Second Cohort

Key CMMI updates to the EOM  The Center for Medicare and Medicaid Innovation (CMMI) released exciting updates to the Enhancing Oncology Model (EOM) along with a new opportunity for a second cohort of participants.   The EOM aims to enhance the quality of care for cancer patients while reducing costs under the Medicare fee-for-service program. The updates come on the heels of lower-than-expected model participation .   This blog will discuss key EOM updates, application details, eligibility requirements and important deadlines.  New cohort opportunity  Request for applications: CMS issued an RFA to recruit a second cohort of participants and payers for the EOM.  Timeline:  Second cohort start date: July 1, 2025  Second cohort end date: June 30, 2030  Initial performance period start date: July 1, 2023  Model test end date for all participants: June 30, 2030 (extended from June 30, 2028)  Notable changes to the EOM model  Model extension: The model's duration is extended by two yea
Post a Comment
Read more

What does healthcare improvement look like in 2024 and beyond?

The healthcare industry has faced many new challenges in recent years. How does this seemingly ever-changing landscape impact healthcare improvement in 2024 and beyond? Based on the Institute for Healthcare Improvement 2023 Forum, quality improvement, safety and culture, equity and a functional delivery system remain top priorities across sectors. This was reflected in the forum agenda , which included 10 tracks and a scientific symposium with three primary focus areas: Quality: Addressing value, cost and quality; diagnostic excellence and improvement science Culture and safety: Building capability, leadership, workforce well-being and patient and workforce safety Patient focus: Equity, person-centered care and population health Since DataGen participated, we’ll give you some exclusive insight into what was discussed so you can better understand what’s driving healthcare in the new year. The future of healthcare improvement: 4 major insights 1. Quality requires a systems approach Th
Post a Comment
Read more